Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-20 Cohen Fred E Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2018-06-20 ABERCROMBIE GEORGE B Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2018-06-01 Sheridan William P Senior VP - CMO Option exercise +42,112 $2.58 $109K 63,170
2018-06-01 Sheridan William P Senior VP - CMO Sale −42,112 $6.30 $265K 21,058
2018-06-01 Sheridan William P Senior VP - CMO Option exercise · Emp. Stock Option (Right to Buy) −42,112 0
2018-06-01 INGRAM ROBERT ALEXANDER Director Grant or award +2,916 $6.43 $19K 21,818
2018-06-01 Hutson Nancy J Director Grant or award +1,555 $6.43 $10K 39,702
2018-05-17 Stonehouse Jon P President & CEO Option exercise +70,427 $1.42 $100K 725,519
2018-05-17 Stonehouse Jon P President & CEO Option exercise · Emp. Stock Option (Right to Buy) −70,427 297,573
2018-05-15 Barnes Alane P VP, General Counsel & Corp Sec Option exercise +12,500 $1.42 $18K 98,268
2018-05-15 Barnes Alane P VP, General Counsel & Corp Sec Shares withheld for taxes −3,004 $5.91 $18K 95,264
2018-05-15 Barnes Alane P VP, General Counsel & Corp Sec Option exercise · Emp. Stock Option (Right to Buy) −12,500 8,132
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Option exercise +20,622 $3.26 $67K 120,618
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Shares withheld for taxes −15,223 $5.18 $79K 105,395
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Option exercise +9,378 $3.26 $31K 114,773
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Shares withheld for taxes −5,902 $5.18 $31K 108,871
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Option exercise · Non-Qualified Stock Option −20,622 0
2018-03-06 Babu Yarlagadda S Senior VP - Drug Discovery Option exercise · Emp. Stock Option (Right to Buy) −9,378 0
2018-03-01 INGRAM ROBERT ALEXANDER Director Grant or award +3,772 $4.97 $19K 18,902
2018-03-01 Hutson Nancy J Director Grant or award +2,012 $4.97 $10K 38,147

Page 37 of 38 · 750 trades